These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7976691)

  • 21. Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis--a prospective randomized study.
    Hofbauer J; Höbarth K; Szabo N; Marberger M
    Br J Urol; 1994 Apr; 73(4):362-5. PubMed ID: 8199822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary lithogen risk test: usefulness in the evaluation of renal lithiasis treatment using crystallization inhibitors (citrate and phytate).
    Conte A; Pizá P; García-Raja A; Grases F; Costa-Bauzá A; Prieto RM
    Arch Esp Urol; 1999 Apr; 52(3):305-10. PubMed ID: 10371752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alkali citrate for preventing recurrence of calcium oxalate stones.
    Hauser W; Frick J; Kunit G
    Eur Urol; 1990; 17(3):248-51. PubMed ID: 2190842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevention of urinary calculi by means of a benzbromarone-citrate combination].
    Bach D; Hesse A; Strenge A; Vahlensieck W
    Fortschr Med; 1980 Nov; 98(44):1752-5. PubMed ID: 7461567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.
    Sakhaee K; Poindexter JR; Griffith CS; Pak CY
    J Urol; 2004 Sep; 172(3):958-61. PubMed ID: 15311008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Calcium-dependent calcium oxalate lithiasis (type IIa). The importance of urinary citrate and the calcium/citrate ratio].
    Boess G; Parent X
    Presse Med; 1999 Apr; 28(15):784-6. PubMed ID: 10325933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lemonade therapy increases urinary citrate and urine volumes in patients with recurrent calcium oxalate stone formation.
    Penniston KL; Steele TH; Nakada SY
    Urology; 2007 Nov; 70(5):856-60. PubMed ID: 17919696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory effect of pyrophosphate, citrate, magnesium and chondroitin sulphate in calcium oxalate urolithiasis.
    Grases F; Genestar C; Conte A; March P; Costa-Bauzá A
    Br J Urol; 1989 Sep; 64(3):235-7. PubMed ID: 2553195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cost-effectiveness analysis of preventive treatment of urinary lithiasis recurrence using potassium citrate].
    Gisbert Gelonch R; Fernández Augusto L
    Arch Esp Urol; 1997 May; 50(4):373-80. PubMed ID: 9313046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Indicators of the risk of calcium oxalate urinary calculi: comparative study of the Parks' and Tiselius' indices, urinary citrate/calciuria ratio, and morning crystalluria].
    Robert M; Boularan AM; Guiter J; Monnier L
    Prog Urol; 1996 Apr; 6(2):264-8. PubMed ID: 8777421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Recurrent oxalocalcium lithiasis. 2: Risk factors and prevention of recurrence of calcium urinary lithiasis].
    Réveillaud RJ; Daudon M
    Rev Prat; 1989 Feb; 39(4):317-23. PubMed ID: 2649970
    [No Abstract]   [Full Text] [Related]  

  • 33. Analysis of calcium, oxalate, and citrate interaction in idiopathic calcium urolithiasis in children.
    Milosević D; Batinić D; Konjevoda P; Blau N; Stambuk N; Nizić L; Vrljicak K; Batinić D
    J Chem Inf Comput Sci; 2003; 43(6):1844-7. PubMed ID: 14632431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Citrate and renal calculi.
    Pak CY
    Miner Electrolyte Metab; 1987; 13(4):257-66. PubMed ID: 3306318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physicochemical considerations in the development and prevention of calcium oxalate urolithiasis.
    Kok DJ; Papapoulos SE
    Bone Miner; 1993 Jan; 20(1):1-15. PubMed ID: 8453319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of aloe (Aloe vera Linn.) on healthy adult volunteers: changes in urinary composition.
    Kirdpon S; Kirdpon W; Airarat W; Trevanich A; Nanakorn S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S9-14. PubMed ID: 17044448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of magnesium salts in preventing experimental oxalate urolithiasis in rats.
    Ogawa Y; Yamaguchi K; Morozumi M
    J Urol; 1990 Aug; 144(2 Pt 1):385-9. PubMed ID: 2374212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylactic and therapeutic properties of a sodium citrate preparation in the management of calcium oxalate urolithiasis: randomized, placebo-controlled trial.
    Allie-Hamdulay S; Rodgers AL
    Urol Res; 2005 May; 33(2):116-24. PubMed ID: 15871014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion.
    Domrongkitchaiporn S; Stitchantrakul W; Kochakarn W
    Am J Kidney Dis; 2006 Oct; 48(4):546-54. PubMed ID: 16997050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.